Vaccine against influenza
POPULARITY
Most mayos, salad dressings and chips “made with 100% avocado oil” fail test; Borderline cholesterol—will a coronary calcium scan help decide whether a statin is warranted? Aged Garlic Extract for blood pressure; Immune benefits of BWH Beta Glucan.
Currently, annual influenza vaccination is recommended for everyone 6 months of age or older who do not have a contraindication, but vaccine uptake was suboptimal among adults and children during the most recent season. In anticipation of influenza season, tune into to this podcast featuring audio from a live webinar to listen as experts Mary Barna Bridgeman, PharmD, BCPS, BCGP, and Jana Shaw, MD, MPH, MS, FAAP, FPIDS, discuss the 2025-2026 influenza season and explore strategies to improve your confidence in optimizing influenza vaccine uptake for pediatric and adult patients. To download the accompanying slides, and view additional activities, visit the program page. Topics covered in this podcast include: Influenza Uptake and Viral Activity During the 2025-2026 Season Influenza Vaccine Selection The Influenza Vaccine Dosing Algorithm for Children Aged 6 Months Through 8 Years Comparative Analysis of Immune Response to Seasonal Inactivated Influenza Vaccines Preferential Recommendations for Older Adults Strategies to Improve Outcomes for the 2026-2027 Season Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. Presenters: Mary Barna Bridgeman, PharmD, BCPS, BCGP Clinical Professor Ernest Mario School of Pharmacy Rutgers, The State University of New Jersey Piscataway, New Jersey Internal Medicine Clinical Pharmacy Specialist Robert Wood Johnson University Hospital-New Brunswick New Brunswick, New Jersey Jana Shaw, MD, MPH, MS, FAAP, FPIDS Professor of Pediatrics, Public Health, and Preventive Medicine Pediatric Infectious Diseases Hospital Epidemiologist, Upstate Golisano Children's Hospital SUNY Upstate Medical University Syracuse, New York Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
The FDA has approved the first mRNA flu shot: Moderna's mFlusiva – but immunologist Dr. Jessica Rose says it safety tests are flawed. “… You will find the safety data that definitively shows that more people died in the context of the mRNA-1010 injectable product than in the comparator group,” writes Dr. Rose. “You should know that the comparator group ALSO were given a flu vaccine – NOT A SALINE PLACEBO.” Reuters reports the approval covers adults 50 and older, based on a late-stage trial of more than 40,000 people that showed the shot was 26.6% more effective than a licensed standard-dose flu vaccine. But Dr. Rose says that no saline placebo was used, and the comparator group also received a flu vaccine – and that the data she's seen indicates high adverse reactions to the new shots. Dr. Kelly Victory, Chief of Emergency & Disaster Medicine at The Wellness Company, joins Wellness Company CEO Peter Gillooly to discuss RFK's push to split the childhood MMR vaccine into separate shots, new releases from Dr. Fauci's pandemic text messages, and TWC's research on Alpha-Gal. Dr. Jessica Rose is a Canadian researcher with a Bachelor's in Applied Mathematics and a Master's in Immunology from Memorial University of Newfoundland. She holds a PhD in Computational Biology from Bar Ilan University and completed postdoctoral research in Molecular Biology and Biochemistry. Follow at https://jessicasuniverse.com Dr. Kelly Victory is Chief of Emergency & Disaster Medicine at The Wellness Company and a trauma and emergency specialist with over 30 years of experience. Follow at https://x.com/DrKellyVictory Peter Gillooly is CEO of The Wellness Company. Through the organization's initiatives and products, he promotes patient-first care and individual control over health decisions. Learn more at https://drdrew.com/twc 「 SUPPORT OUR SPONSORS 」 • BIOPRO - BioPro+® is a natural formula of growth factors and peptides that support how you look, feel & perform. Learn more at https://drdrew.com/biopro • FATTY15 – The future of essential fatty acids is here! Strengthen your cells against age-related breakdown with Fatty15. Get 15% off a 90-day Starter Kit Subscription at https://drdrew.com/fatty15 • PALEOVALLEY - "Paleovalley has a wide variety of extraordinary products that are both healthful and delicious,” says Dr. Drew. "I am a huge fan of this brand and know you'll love it too!” Get 15% off your first order at https://drdrew.com/paleovalley • THE WELLNESS COMPANY - Counteract harmful spike proteins with TWC's Signature Series Spike Support Formula containing nattokinase and selenium. Learn more about TWC's supplements at https://twc.health/drew • CHAPTER - For free and unbiased Medicare help, dial (218) 521-2472 to speak with my trusted partner, Chapter, or go to https://askchapter.org/drdrew Chapter and its affiliates are not connected with or endorsed by any government entity or the federal Medicare program. Chapter Advisory, LLC represents Medicare Advantage HMO, PPO, and PFFS organizations and stand alone prescription drug plans that have a Medicare contract. Enrollment depends on the plan's contract renewal. While we have a database of every Medicare plan nationwide and can help you to search among all plans, we have contracts with many but not all plans. As a result, we do not offer every plan available in your area. Currently we represent 50 organizations which offer 18,160 products nationwide. We search and recommend all plans, even those we don't directly offer. You can contact a licensed Chapter agent to find out the number of products available in your specific area. Please contact Medicare.gov, 1-800-Medicare, or your local State Health Insurance Program (SHIP) to get information on all of your options. 「 ABOUT THE SHOW 」 This show is for entertainment and/or informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment. Executive Producers • Kaleb Nation - https://kalebnation.com • Susan Pinsky - https://x.com/firstladyoflove Content Producer • Emily Barsh - https://x.com/emilytvproducer Learn more about your ad choices. Visit megaphone.fm/adchoices
JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "What to Know About the mRNA Flu Vaccine, Newly Approved by the FDA." Related Content: What to Know About the mRNA Flu Vaccine, Newly Approved by the FDA
Clancy Overell, Errol Parker and Wendell Hussey wrap up all the biggest stories from the week - live from the Desert Rock FM studio in downtown Betoota.Click here for up to 45% off Subscribe to the Betoota Newsletter HERE Betoota on Instagram Betoota on TikTokSee omnystudio.com/listener for privacy information.
Dr. Velva Boles—renowned physician and scientist—returns to our classroom with her expert insights. Dr. Boles, who bravely raised early concerns about the COVID-19 vaccine, will break down Dr. Anthony Fauci’s Congressional testimony and discuss what it means for you and your loved ones. She’ll also deliver the latest updates on the new flu vaccine and answer YOUR pressing health questions. That’s not all: experience the wisdom of Brother Amde from the legendary Watts Prophets, and hear firsthand from Benton Harbor’s courageous activist, the Revd. Ed Pickney, as he recounts his powerful exchange with Michigan Democratic Senator nominee Dr. Abdul El-Sayed.See omnystudio.com/listener for privacy information.
Tonight on America At Night with McGraw Milhaven, Dr. Omer Awan, physician and senior public health contributor for Forbes, explains the new mRNA-based flu vaccine, what makes this approach different and what the changes to childhood vaccine policy could mean for families and public health. Dr. Jennifer Sciubba, demographer, President and CEO of the Population Reference Bureau and author of 8 Billion and Counting, examines the changing demographic picture in the U.S. and Europe, including falling birth rates, aging populations, migration and what these trends could mean for the future. Plus, Donna Gibson, Executive Director of Friends of Flight 93, looks ahead to the 25th observance of September 11, 2001, and the ongoing work to honor the passengers and crew of Flight 93 at the Flight 93 National Memorial. Learn more about your ad choices. Visit podcastchoices.com/adchoices
යහපත් නිරෝගී දිවිපෙවෙතකට වැදගත් වන සෞඛ්ය උපදෙස් හා තොරතුරු ගෙනෙන විශේෂාංගය. මෙම වැඩසටහන ඉන්ෆ්ලුවෙන්සා වෛරසය හා ඉන් ආරක්ෂා වන ආකාරය පිළිබඳවයි.Find our podcasts in the SBS Sinhala podcast collection. You can listen to the SBS Sinhala podcasts on the SBS South Asian YouTube channel.Tune in to the SBS Sinhala live radio at 11 am on Monday, Tuesday, Thursday, and Friday via SBS South Asian digital radio, channel 302 or 305 on your television, or live stream on the SBS Sinhala website. Or visit SBS tune-in page to find your area's SBS radio frequency.Download the SBS Audio App for easy access to our live radio and podcasts. For the latest updates, visit SBS Sinhala Facebook.
Newly released text messages show Dr. Anthony Fauci and top health officials privately discussing vaccine concerns while publicly promoting them!
Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about the FDA approving a new mRNA flu vaccine.
Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about the FDA approving a new mRNA flu vaccine.
Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about the FDA approving a new mRNA flu vaccine.
The heatwave may be on the way back. But in a few weeks, we will be back to the cold and flu season. Fianna Fáil MEP Billy Kelleher explained to Anton why he wants to see a review of high-dosage flu vaccines ahead of the next winter season.
The government will roll out a vaccine against the deadly H5N1 bird flu in priority for native species in captivity.
The heatwave may be on the way back. But in a few weeks, we will be back to the cold and flu season. Fianna Fáil MEP Billy Kelleher explained to Anton why he wants to see a review of high-dosage flu vaccines ahead of the next winter season.
Broadcast from KSQD, Santa Cruz on 8-06-2026: >ul> An emailer with persistent nine-month nerve damage in her right leg after a hysterectomy asks whether peptides could help. Dr. Dawn attributes the injury to lithotomy positioning during surgery, then reviews the main nerve-regeneration candidates in the FDA peptide review pipeline: BPC-157 (Body Protection Compound, strong rat data on sciatic nerve recovery with thicker myelin sheaths), intracellular sigma peptide (targets glial scar CSPGs blocking CNS regrowth), C3 peptide 156-181, GHK-Cu (copper peptide, upregulates nerve growth factor and neurotrophin-3), self-assembling hydrogel scaffolds for bridging nerve gaps, ARA-290/cibinetide (an erythropoietin fragment with early small fiber neuropathy trial data), and Semax (used internationally for stroke rehab). She adds standard functional-medicine adjuncts: alpha-lipoic acid, methylated B12, and methylfolate at high doses for six months. An emailer asks about safe features when buying an infrared sauna. Dr. Dawn covers three concerns: EMF exposure (look for shielded/grounded heaters testing under 1 milligauss at seat level, avoid unshielded Wi-Fi and Bluetooth panels); VOC off-gassing (avoid plywood, particle board, and MDF because of formaldehyde and benzene release, and avoid Western red cedar and pine because of high terpene emissions and instead choose poplar, basswood, or eucalyptus); and avoid built-in oxygen ionizers, which produce ozone as a coronal-discharge byproduct that irritates airways and generates secondary oxygenated VOCs. Dr. Dawn covers the surprisingly long list of medications that raise estrogen in middle-aged men—including nearly all antidepressants and antiepileptics, statins, NSAIDs (specifically naproxen and indomethacin but not ibuprofen), most blood pressure medications, PPIs, H2 blockers, Parkinson's drugs, antihistamines, and muscle relaxants. She recommends annual monitoring of the estrogen-to-testosterone ratio and offers rebalancing options: topical chrysin (blocks aromatization), indole-3-carbinol, calcium D-glucarate (blocks enterohepatic estrogen recirculation), soy (competitive receptor inhibition), and grape skin extract. The first mRNA-based flu vaccine was approved this week for adults 50 and over. Beyond the 27% improvement in seasonal efficacy over conventional shots, the strategic advantage is manufacturing speed. This will be critical when or if bird flu mutates to respiratory human transmission. Since mRNA vaccine can be reprogrammed from a new viral sequence in weeks versus the three-to-four-month growth cycle for conventional flu vaccines, rapid response can save lives. But mRNA vaccine side effects include more injection-site pain and fatigue - more like a tetanus shot than a traditional flu shot.. A Spanish prospective study of chemicals affected puberty in the young studied 500 girls followed from ages 7-10 and again at 14-16 used urine chemical measurements as objective exposure markers rather than food diaries. Ethylenethiourea, a metabolite of dithiocarbamate fungicides used heavily on strawberriess,was associated with earlier menarche, while a chlorpyrifos metabolite was associated with delayed menarche. this latter effect was more pronounced in overweight girls whose fat tissue concentrated the compound. Dr. Dawn recommends organic strawberries and keeping children away from fumigated fields. University of Pennsylvania School of Dental Medicine researchers developed a chewing gum from lablab beans containing the natural antiviral protein FRIL, which reduced oral HPV by up to 93% in samples from head and neck squamous cell carcinoma patients. The gum also suppressed Fusobacterium nucleatum and Porphyromonas gingivalis, oral bacteria that promote cancer recurrence. Michigan State University's Hamburger lab studying delphinium (larkspur) alkaloids joined forces with Tomáš Pluskal's Czech Academy of Sciences lab studying wolfsbane (monkshood) after meeting at a Barcelona conference. Together they mapped the biosynthetic assembly line for aconite—an alkaloid with valuable applications against malaria, pain, cancer, and agricultural pests but impossibly slow to extract from source plants—and cloned the pathway into tobacco, which grows aggressively and produces large quantities of the compound. An emailer named in the message asks about an incidentally-discovered enlarged aorta on CT. Dr. Dawn notes it officially becomes an aneurysm at 4 cm (annual monitoring) or 5 cm (six-month monitoring), with smoking cessation critical since tobacco directly weakens the aortic wall. She describes the "zipper of fire" back pain of dissection versus catastrophic rupture, and notes Medicare covers a one-time screening ultrasound for ever-smokers over 65.
Why is the GOP establishment cheering the defeat of true conservatives while a deadly NEW mRNA flu vaccine gets rubber-stamped under its watch? Because the GOP is as negative effective for us politically as the COVID shots and mRNA that Trump supports. I'm joined by epidemiologist Nic Hulscher who reveals the horrifying truth about Moderna's newly FDA-approved mRNA flu vaccine. With zero true placebo control groups and a 75% adverse reaction rate in trials, this new injection is being rolled out under the conservative banner. You will hear why stopping the mRNA platform is the defining pro-life issue of our time and why the medical freedom movement is being betrayed in broad daylight. I also delve into the tragic defeat of Tennessee conservative Rep. Andy Ogles by a Democrat-backed Green Energy PAC — a subversion completely facilitated by the GOP infrastructure and ignored by MAGA inc. that fake-fights the GOP establishment. Learn more about your ad choices. Visit megaphone.fm/adchoices
Senators race to handle Todd Blanche's confirmation as Attorney General, the late Lindsey Graham's Russia sanctions bill, a deal to fund the government, and more. Plus, the FDA clears Replimune's melanoma drug and Moderna's mRNA influenza shot. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
The FDA has approved a new flu vaccine that uses mRNA technology. Dr. Céline Gounder reports. A record number of U.S. adults are moving back in with their parents. Dr. Gail Saltz, a psychiatrist at NewYork-Presbyterian Hospital and Weill-Cornell Medical College, and CBS News business analyst Jill Schlesinger explain what's behind the trend, and how to make it work. Amanda Kloots, a Broadway dancer, podcast host and best friend to reality star Harry Jowsey, joins "CBS Mornings" to discuss their new Netflix series "Let's Marry Harry." Matt Walker, a geneticist and the CEO of Kindred Companion Sciences, joins "CBS Mornings" with his gene-altered beagle, Bailey, to discuss creating future options for people with severe pet allergies. Diarra Kilpatrick, who stars in "Diarra from Detroit," joins "CBS Mornings" to discuss the show's new season, which premiered on Paramount+ last week
In Kim on a Whim, Kim St. Onge and guest host Heidi Harris critique public health messaging surrounding Moderna's newly approved mRNA seasonal influenza vaccine targeting adults aged 50 to 64. Kim reviews local news coverage from KMOV and Washington University clinical research studies, contrasting traditional egg-based vaccine efficacy against reported mRNA side-effect rates. Kim shares personal experiences navigating local emergency care facilities following a minor injury involving her young son, while Heidi and Kim examine intake documentation forms and discuss public health communication strategies. Hashtags: #KimOnAWhim #HeidiHarris #mRNAVaccine #Moderna #PublicHealth #LocalNews #KMOV
Hour 1 opens with guest host Heidi Harris filling in for Marc Cox alongside Kim St. Onge and producer Ethan Bright. Heidi reflects on parenting transitions before addressing ongoing congressional investigations into former NIAID Director Dr. Anthony Fauci, featuring commentary from Senator Rand Paul, Senator Ron Johnson, and sports commentator Stephen A. Smith regarding newly subpoenaed phone records. In Segment 2, Heidi and Kim examine the Senate panel's vote to hold Dr. Fauci in contempt of Congress, contrasting pandemic-era business closures and religious gathering restrictions against large-scale public events. Segment 3 features Kim on a Whim, where Kim breaks down FDA approvals and clinical trial data for Moderna's new mRNA seasonal flu shot, alongside regional reporting on urgent care intake protocols. Hour 1 wraps up with Segment 4's discussion on veterinary vaccine technology and pediatric medical practice guidelines. Hour Hashtags #HeidiHarris #KimStOnge #DrFauci #RandPaul #SenateContempt #KimOnAWhim #mRNAVaccine #PublicHealth
Joyce Talks about :Lack of families serving in the US military may be leading to the decline in America pride and respect for the military. Conservative media now criticizing the Trump Administration.President Trump's historically low approval numbers due to the economy and the war in Iran. Socialist movement gaining speed because their promises appeal to struggling American people. MRNA flu vaccine roll out. Black-balled NBA player declares himself a prospect for the WNBA to challenge it's acceptance of trans-athletes. Declassified documents shows investigation into whether President Trump was working with Russia after his firing of James Comey. Derek from TMZ calls in to talk about Perez Hilton suicide attempt, influencers making millions and future of communication, influencer Sydney Towle's cancer battle, and Courtney Clenney case update. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
KMOX Health Editor Fred Bodimer talked with Washington University Medicine Immunologist Dr. Hanover Matz who studied the vaccine when it was in the clinical trial stage.
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're delving into a series of pivotal advancements that underscore the dynamic nature of our industry. Starting with Moderna, which has recently secured FDA approval for its mRNA-based influenza vaccine, MFLUSIVA. This marks a monumental leap in leveraging mRNA technology beyond its initial role in COVID-19 vaccine development. The approval not only highlights the technology's adaptability and efficiency but also hints at a transformative future for seasonal vaccines, potentially allowing for rapid responses to influenza virus mutations. In tandem with this development, Takeda has achieved FDA approval for Orzeyful (Oveporexton), an innovative therapy targeting narcolepsy type 1. This represents a significant breakthrough as it targets the root cause of the disorder through orexin receptor modulation. The implication here is profound—offering new hope for patients who have long been underserved by existing treatments and potentially setting a new standard in managing sleep disorders. On the leadership front, Sarepta Therapeutics welcomes new CEO Michael Severino during a critical growth phase. Known for its focus on rare diseases, Sarepta faces the challenge of maintaining its competitive edge and meeting stakeholder expectations in a rapidly evolving market landscape. Meanwhile, AstraZeneca and CSPC Pharmaceutical are enhancing their manufacturing capabilities through a joint venture aimed at bolstering biologics production in China—a strategic move that positions them well within one of the fastest-growing markets for such treatments. This partnership is expected to accelerate the availability of biologic therapies across Asia. In another significant leadership change, Fujifilm Biotechnologies appoints Maja Pedersen as president, signaling a strategic shift towards strengthening its contract development and manufacturing organization operations. This move is reflective of broader industry trends emphasizing operational efficiency and strategic restructuring amid changing market demands. Elsewhere, Emergent BioSolutions has eliminated its top R&D role as part of sweeping restructuring efforts. This decision underscores ongoing challenges companies face in balancing innovation with operational efficiency amidst market pressures. In legal arenas, Galderma Laboratories emerged victorious over Sanofi regarding claims made about its blockbuster drug Dupixent. This victory highlights the importance of substantiating promotional claims in an increasingly competitive pharmaceutical marketing landscape. Turning to clinical trials, Biovie's recent study on Parkinson's disease has sparked debate due to its emphasis on composite endpoints rather than primary ones. While offering insights into specific patient subgroups, this approach raises questions about trial design and result interpretation—a critical factor for drug development success. Investment activities are also shaping industry trends significantly. Notably, Lifemine Therapeutics has secured substantial funding from high-profile investors like Bill Gates and Jeff Bezos. This investment reflects burgeoning interest in innovative biotech platforms capable of addressing complex diseases through unique mechanisms. Moreover, Icon's collaboration with Anthropics aims to integrate AI into clinical trials—an exciting development poised to streamline these processes significantly. By leveraging artificial intelligence capabilities, this partnership could accelerate drug development timelines and improve trial outcomes. Overall, these developments highlight transformative changes within the pharmaceutical and biotech sectors. Innovative therapeutics, strategic partnerships, leadership transitions, regulatory milestones, and technological advancements collectively drive significant progress in patient care and drug development. As we navigate these changes, it's crucial for industry stakeholders to capitalize on emerging opportunities while addressing associated challenges such as regulatory compliance, market competition, and operational efficiencies. Thank you for tuning into Pharma Daily—stay informed and stay ahead!Support the show
Aug. 7, 2026 ~ Dr. Matthew Sims, director of infectious diseases research at Corewell Health in Southeast Michigan, joins the show to discuss the first mRNA-based flu shot approved by the FDA. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.
-OpenAI discovered and shut down the message board on July 4, but the agents found another way to rebuild it for communication by the 8th. -Known as mFlusiva, the immunization is effective against the four most common strains of influenza and has been in human testing trials since 2021 -The new terminal-based coding tool is powered by Muse Spark 1.2, a new version of Meta's AI model which offers "improvements in code generation, complex debugging, codebase understanding, and end-to-end developer workflows." Learn more about your ad choices. Visit podcastchoices.com/adchoices
Votes in Michigan's highly anticipated Democratic Senate primary are still being counted. But what do the results in Tuesday's other races tell us about November's election? The U.S military is running short of ammunition. NPR has learned that the Army is running out of long-range attack missiles. And the Food and Drug Administration is deciding whether to approve the first flu vaccine using mRNA technology.Want more analysis of the most important news of the day, plus a little fun? Subscribe to the Up First newsletter.Today's episode of Up First was edited by Larry Kaplow, Andrew Sussman, Scott Hensley, HJ Mai and Olivia Hampton.It was produced by Ziad Buchh and Nia Dumas.Our director is Christopher Thomas.We get engineering support from Neisha Heinis and Patrick Murray. Our technical director is Carleigh Strange.And our Supervising Producer is Michael Lipkin.Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show's perks include sponsor-free listening. Learn more at plus.npr.org.(0:00) Introduction(01:49) Primary Election Results(05:40) US Missile Stockpiles Running Low(09:19) New Flu VaccineSee pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy Policy
Africa Melane speaks to a representative from the National Institute for Communicable Diseases (NICD) about South Africa's winter flu season, the strains currently circulating, who is most at risk, and why vaccination remains the best protection against severe illness. Early Breakfast with Africa Melane is 702’s and CapeTalk’s early morning talk show. Experienced broadcaster Africa Melane brings you the early morning news, sports, business, and interviews politicians and analysts to help make sense of the world. He also enjoys chatting to guests in the lifestyle sphere and the Arts. All the interviews are podcasted for you to catch-up and listen. Thank you for listening to this podcast from Early Breakfast with Africa Melane For more about the show click https://buff.ly/XHry7eQ and find all the catch-up podcasts here https://buff.ly/XJ10LBU Listen live on weekdays between 04:00 and 06:00 (SA Time) to the Early Breakfast with Africa Melane broadcast on 702 https://buff.ly/gk3y0Kj and CapeTalk https://buff.ly/NnFM3N Subscribe to the 702 and CapeTalk daily and weekly newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.
(Jul 10, 2026) In many rural areas of New York and the US, there's a critical shortage of healthcare providers. Physician assistants say that modernizing the way that they're allowed to practice could help address the shortage; the military is rolling back its decision to make the flu vaccine voluntary after an outbreak sickened 280 people in Texas; and, we'll get a preview of Ogdensburg's new concert series happening throughout the summer on the banks of the St. Lawrence River.
Visuals: https://getbehindthebillboard.com/episode-112-tom-richards Episode #112 features Tom Richards, Global CCO at 21GRAMS. Tom, alongside Frank Mazzola, has led 21GRAMS to be ranked as the world's third most creative health agency. Prior to 21GRAMS, Tom had great success at Havas Lynx, leading them to win Healthcare Agency of the Year at Cannes in 2018. We started with the Roy Castle Foundation ‘Smoking in Three Easy Steps' poster from Cheetham Bell, Manchester where Tom created smoke rings with real cigarettes, which were then shot and adapted to create the headline. Next came two brilliant campaigns - milk bottle and Santa - for the Scottish National Blood Transfusion Service from Faulds in Edinburgh, While for Eurocamp we discussed dog-friendly holidays and three wonderfully happy looking doggies shot by Euan Myles which made it into D&AD. And then we discussed Tom's move into Pharma and more brilliant work, including the world's first ever Sneezing poster for the Flu Vaccine. And ADHD Rollercoasters - a beautifully crafted campaign that highlights the conditions of this increasingly common neurodevelopmental disorder. Thanks so much Tom for breaking your busy schedule to come and chat to us. Thanks to all our sponsors, who make the show possible: Bauer Media Outdoor View2Fill Super Optimal GAS Music
This week primary care physicians Kate Rowland, Mark Ebell, Gary Ferenchick and Henry Barry discuss four new studies: screentime for children, discontinuing levothyroxine, a new mRNA flu vaccine from Moderna, and nicotinamide adenine dinucleotide (NAD) Supplementation for healthy aging.Links to articles:AAP screen time policyDiscontinuing levothyroxine studymRNA flu vaccine from ModernaNAD supplementsQuiz: Bixomania study
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about asundexian reducing recurrent ischemic stroke, the link between the high-dose flu vaccine and Alzheimer's dementia incidence, and the evolving role of osteopathic medicine in neurology.
A month after flu shots became voluntary, influenza began to burn through boot camp at Lackland Air Force Base. Hundreds have been sickened, and infectious diseases experts are not surprised.
The Matthew Dark Show-Hit subscribe and never miss an episode! rumble.com/c/TheMatthewDarkShow
MAHA feels like a distant memory as we are not seeing any progress to speak of. The FDA voted 9-0 to approve Moderna's Flu vaccine this fall and for the first time ever it will be mRNA. We know the risks with mRNA having just seen that technology with Covid-19. Hit subscribe and never miss a show!
Guests Include: Landmark Legal's Micheal O'Neill, Strategic Vision's David Johnson, Americans for Tax Reform's Grover Norquist, Documentary Film Maker and Missionary Judd Saul, Senator Ron Johnson, Lt. Gubernatorial Candidate Will Martin
In this week's episode, Jess chats with Dr. Sarah Nosal to discuss the importance of adult vaccines, including shingles, HPV, flu, COVID, RSV, and more. They cover vaccine recommendations, personal experiences, and address common questions to help listeners make informed health decisions. We'd like to thank the American Academy of Family Physicians for sponsoring today's episode and helping us bring awareness to adult vaccines! Watch the convo on YouTube: https://youtu.be/QKpau8xcMTk (00:00) Intro & Public Health Update (04:12) Shingles Vaccine (11:37) HPV Vaccine (18:35) Flu Vaccine (25:23) COVID Vaccine (27:19) RSV Vaccine (30:15) Meningitis Vaccine (31:19) Chicken Pox/Varicella Vaccine (32:22) Adult Boosters For Childhood Vaccines (34:29) Vaccination During Pregnancy (36:09) Is There An Adult Vaccine Schedule? (38:39) First Time Grandparent Vaccine Recommendations (39:38) Final Thoughts https://www.acog.org/clinical-information/maternal-immunization-schedule https://www.aafp.org/about/leadership/board/sarah-nosal https://www.aafp.org/clinical-insights/immunizations-and-vaccines/immunizations-schedules-resourceshhttps://familydoctor.org/the-importance-of-vaccinations/ https://familydoctor.org/vaccines-myth-versus-fact/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
ඕස්ට්රේලියාවේ ලබාදෙන flu vaccine එක ගැන තිබෙන දුර්මත සහ ගැටළු පිළිබඳව SBS සිංහල සේවය සිදු කල සාකච්ඡාවට සවන්දෙන්න.
The benefits of getting a shingles vaccine seem relatively straightforward: It will prevent you from getting shingles, a painful rash caused by the same virus that causes chickenpox. But researchers have found a surprising link between getting the shingles vaccine and a lower risk of developing dementia. And that's not the only vaccine that seems to have additional benefits. So what's going on here? To help explain this research are epidemiologist Pascal Geldsetzer, who studies the association between the shingles vaccine and lower rates of dementia; and physician and epidemiologist Helen Chu, who studies the Flu, RSV and COVID-19 viruses. Guests: Dr. Pascal Geldsetzer is an assistant professor of medicine, epidemiology and population health at Stanford University. Dr. Helen Chu is a professor of epidemiology, allergy and infectious diseases at the University of Washington. Other episodes you may enjoy: Study Finds COVID mRNA Vaccines Boost Cancer Treatment As Cervical Cancer Deaths Plummet, Experts Credit HPV Vaccine Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that's keeping you up at night? Call us: 877-472-4374 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
The Associate Health Minister's praising a proposal to offer free flu jabs to more people. Pharmac's looking at providing the jabs to an extra 260 thousand children between six months and five-years-old from next year. It's also proposing introducing two new brands for over 65s. David Seymour told Mike Hosking some young people still die every year from influenza, and as every parent knows, they also spread it around the household. He says the cost-benefit of this stacks up, and it's a great thing for Pharmac to be looking into. Consultation opens mid-June. LISTEN ABOVE See omnystudio.com/listener for privacy information.
In today's episode, Larry joins Angie to discuss the Department of War's recent decision not to mandate the flu vaccine for military members. Military personnel can still obtain the vaccine if they want it, but it is no longer required. Tune in!
A new trial is starting this summer, as part of a programme to develop a vaccine for people against bird flu. 3000 volunteers are needed from the UK to take part, and 1000 in the USA. Researchers at the National Institute for Health and Care Research are hoping that poultry workers might take part.A new report warns that UK farming's reliance on imported fertiliser and minerals, puts it at risk in times of geopolitical stress. Analysis, published by the National Preparedness Commission, highlights the fragility of global supply chains on which UK agriculture depends.Fuel and fertiliser costs are soaring because of disruption caused by the war in the Middle East. That's having a big impact on farmers and it's also putting pressure on food prices as MPs on the Environment Food and Rural Affairs select committee have been hearing. They were told that food prices were 40% higher than before Covid and that the food supply chain needed urgent government support with fuel costs.We visit a field trial of a gene-edited barley which contains higher levels of fat. Scientists believe this will make it a more efficient livestock feed, and could also reduce methane emissions by making it more digestible.Thatching is becoming more of a challenge due to issues with some of the materials. Supplies of the right sort of wheat straw can be unpredictable and the hazel spars used to attach the thatch to the roof now have to be imported from Eastern Europe. To kick start interest in growing more locally a ‘summit' of thatchers, farmers and plant scientists was held this week in Suffolk.Presenter = Charlotte Smith Producer = Rebecca Rooney
AP correspondent Ed Donahue on new Pentagon rules about flu shots.
It’s Friday, so we’re wrapping up the week with a look at the stories making us smile. First, there’s a big win for parents as flu season approaches: a new needle-free ‘FluMist’ nasal spray is now available for kids and teens. We check in on which states are offering it for free to help keep the family healthy this winter. Then, we dive into the ‘viral’ moment that had the McDonald’s CEO’s own kids calling him out for his burger-tasting technique. Plus, we celebrate some truly legendary longevity as we clear up the headlines surrounding Jonathan, the world’s oldest tortoise.
Tara breaks down today's top stories: Israel's covert and overt operations against Iran, the strategic moves reshaping oil markets, domestic security failures, and what you're not being told about flu and COVID vaccines. From geopolitics to public health, this episode exposes the untold connections influencing your world. SUMMARY Middle East & Iran Conflict: Iran's new leadership remains unseen publicly; proof of life is still demanded by many. Israel is leading covert operations, striking Hezbollah targets across Lebanon and taking out key Iranian nuclear scientists. Limited U.S. forces may be deployed in strategic zones, like the Strait of Hormuz, to control oil flow and pressure Iran economically. Regional conflict impacts 12+ countries, influencing Arab nations, Russia, India, China, and NATO dynamics. Israel's intelligence and military actions prevent a broader escalation and protect U.S. strategic interests. Global Energy & Oil Markets: Trump's lifting of Russian oil sanctions threatens to dramatically lower global oil prices, reversing artificial inflation caused by prior sanctions. Lower oil prices impact U.S. households, the global economy, and geopolitical leverage, including pressure on China and Russia. Democrats are panicking over oil price drops and the potential shift in global energy control. Public Health Insights: Flu vaccines: CDC reports 20–25 deaths per year, potentially underreported by 10x, with effectiveness as low as 25%. COVID vaccines: Adenovirus-based vaccines linked to rare blood clots; media coverage downplays risks and avoids full disclosure. Tara emphasizes informed consent, questioning medical guidance, and reviewing CDC data critically. Domestic Security & Policy Failures: Terror incidents in the U.S., including individuals with Hezbollah contacts, highlight gaps in immigration and gun enforcement policies. Straw purchasing loopholes and DOJ enforcement failures contributed to weapons ending up in criminal hands. Biden-era policies are analyzed as exacerbating domestic vulnerability to terrorist threats. Political Context & Strategy: U.S. global strategy is reshaping alliances, constraining Iran, and influencing energy flows. Trump's moves in energy, military readiness, and sanctions highlight contrasts with prior administration policies. Changes affect global power structures, including NATO, Russia, China, and Latin America, creating a pivotal historical inflection point. KEY TALKING POINTS Israel's multi-front operations in Lebanon and Iran Strategic implications of potential U.S. limited ground operations in the Middle East Global oil markets and Russian sanctions reversal Vaccine safety, CDC reporting, and public awareness Domestic security, immigration, and gun enforcement failures Broader geopolitical effects on NATO, China, Russia, and Latin America SOCIAL MEDIA BLURB Israel strikes, Iran tensions, global oil shocks
From the Middle East to global energy markets, Tara breaks down the strategic moves reshaping the world. Learn how Israel and the U.S. are countering Iran, the risks for Marines on the ground, the geopolitical ripple effects on Russia, China, and Venezuela, and why Democrats are panicking over Trump's energy moves. Plus, get insights on flu and COVID vaccines and what the CDC isn't emphasizing. SUMMARY In this episode, Tara dives deep into international conflict, energy policy, and public health: Middle East & Iran War: The new Iranian leadership has not been publicly seen—proof of life remains unverified. Israel plays a pivotal role in countering Iran and Hezbollah, carrying out strikes, intelligence operations, and targeted removals of Iranian nuclear scientists. Limited U.S. ground operations may be deployed in key strategic areas like the Strait of Hormuz, aiming to cripple Iran's oil economy. The broader regional impact spans 12 countries, influencing alliances with Arab nations, Russia, India, China, and NATO dynamics. Energy & Oil Policy: Trump's moves to lift certain Russian oil sanctions are set to drop global oil prices, reversing Democrat-inflated energy costs caused by prior sanctions. These shifts have major implications for U.S. households, global oil markets, and geopolitical power, including China's economic positioning and Russia's oil influence. Public Health Spotlight: Flu vaccines: 200–250 reported deaths annually, possibly up to 1,000 due to underreporting; CDC reports vaccine effectiveness as low as 25% and often readjusted downward over time. COVID vaccines: Adenovirus-based vaccines linked to rare but dangerous blood clots, with media coverage downplaying the risks. Tara emphasizes informed consent and questioning medical advice. Domestic Security & Policy: Highlights recent terror-related incidents in the U.S., including attacks linked to Hezbollah and ISIS, and how failures in immigration and gun law enforcement contributed. Straw purchasing and federal gun enforcement policies under Biden are analyzed as contributing factors to domestic security vulnerabilities. KEY TALKING POINTS Israel's intelligence and military operations against Iran and Hezbollah Strategic implications of potential U.S. limited ground operations Trump's energy policy and lifting of Russian oil sanctions Impact on global oil prices, Russia, China, India, and NATO CDC data on flu and COVID vaccine effectiveness and risks Domestic terror threats, immigration policy failures, and gun enforcement issues SOCIAL MEDIA BLURB From Iran to oil markets, Israel to U.S. Marines, Tara exposes the strategies reshaping the world
Rescue teams are searching for missing skiers caught in an avalanche near Lake Tahoe amidst a winter storm. After a setback, authorities continue to canvass neighborhoods for clues in the disappearance of Nancy Guthrie. We'll tell you about another set of deadly US strikes on suspected drug-smuggling vessels. The FDA has reversed course and agreed to review a major drugmaker's flu vaccine. Plus, a software giant says it's on track to invest billions to help low incomes countries gain access to AI. Learn more about your ad choices. Visit podcastchoices.com/adchoices
The U.S. Food and Drug Administration announced recently that it will not review Moderna's mRNA flu vaccine, despite late-stage trials showing it was safe and effective. The rejection has many in and outside the industry concerned about the Trump administration's approach to vaccine development and recommendations. Amna Nawaz discussed more with Michael Osterholm. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy
We get the latest from the Munich Security Conference, where U.S. Secretary of State Marco Rubio delivered a speech before European leaders. We also look at the reasons behind why the FDA rejected Moderna's new flu vaccine and how that decision could shape future clinical trials. Plus, we'll look at the what happened with U.S Olympic figure skater Illia Malinin, dubbed the "Quad God," on the ice yesterday. Tipped to win the gold, Malinin didn't end up even medaling. Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy